Evidence map›Paper›PMID 37662015›Full record

ArticleFrontiers in cellular and infection microbiology2023

Antibacterial activity of the novel compound Sudapyridine (WX-081) against

Wenjuan Nie, Shan Gao, Lei Su, Lina Liu, Ruixue Geng, Yingxia You, Naihui Chu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. IncreasingMicrobiology spectrum · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wenjuan NieTuberculosis Department, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Shan GaoTuberculosis Department, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Lei SuTuberculosis Department, Henan Anyang City Tuberculosis Prevention and Control Institute, Anyang, China.
Lina LiuTuberculosis Department, Hengshui Third People's Hospital, Hengshui, China.
Ruixue GengTuberculosis Department, Hohhot Second Hospital, Hohhot, China.
Yingxia YouTuberculosis Department, Zhengzhou Sixth People's Hospital, Zhengzhou, China.
Naihui ChuTuberculosis Department, Beijing Chest Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to investigate sudapyridine (WX-081) antibacterial activity against Methods: WX-081 Results: Drug sensitivity testing of Conclusion: WX-081 effectively inhibited

Indexed as

AzithromycinMycobacterium abscessusAnimalsAnti-Bacterial AgentsIsocyanatesPyridinesZebrafishAnti-Bacterial AgentsAzithromycinIsocyanatesmethyl isocyanatePyridinessudapyridineactivityin vivoMycobacterium abscessusSudapyridinezebrafish

Identifiers

PMID37662015
PMCPMC10471480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.